236 related articles for article (PubMed ID: 38250895)
41. Vaccinations in patients with hematological malignancies.
Tsigrelis C; Ljungman P
Blood Rev; 2016 Mar; 30(2):139-47. PubMed ID: 26602587
[TBL] [Abstract][Full Text] [Related]
42. [Vaccinations for immunocompromised hosts – focussing on patients after a hematological stem cell or organ transplantation, with HIV or with functional or anatomical asplenia].
Staehelin C; Hirzel C; Hauser C; Furrer H
Ther Umsch; 2016; 73(5):281-9. PubMed ID: 27268453
[TBL] [Abstract][Full Text] [Related]
43. Surveillance of Vaccination Coverage Among Adult Populations -United States, 2018.
Lu PJ; Hung MC; Srivastav A; Grohskopf LA; Kobayashi M; Harris AM; Dooling KL; Markowitz LE; Rodriguez-Lainz A; Williams WW
MMWR Surveill Summ; 2021 May; 70(3):1-26. PubMed ID: 33983910
[TBL] [Abstract][Full Text] [Related]
44. Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 2: Inactivated Vaccines.
Jones JL; Tse F; Carroll MW; deBruyn JC; McNeil SA; Pham-Huy A; Seow CH; Barrett LL; Bessissow T; Carman N; Melmed GY; Vanderkooi OG; Marshall JK; Benchimol EI
J Can Assoc Gastroenterol; 2021 Aug; 4(4):e72-e91. PubMed ID: 34476339
[TBL] [Abstract][Full Text] [Related]
45. [Vaccinations in rheumatology].
Feuchtenberger M; Voll RE; Kneitz C
Z Rheumatol; 2010 Nov; 69(9):803-12. PubMed ID: 21063829
[TBL] [Abstract][Full Text] [Related]
46. Immunizing patients with systemic lupus erythematosus: a review of effectiveness and safety.
O'Neill SG; Isenberg DA
Lupus; 2006; 15(11):778-83. PubMed ID: 17153850
[TBL] [Abstract][Full Text] [Related]
47. Use of interleukin 12 to enhance the cellular immune response of swine to an inactivated herpesvirus vaccine.
Zuckermann FA; Martin S; Husmann RJ; Brandt J
Adv Vet Med; 1999; 41():447-61. PubMed ID: 9890035
[TBL] [Abstract][Full Text] [Related]
48. [Vaccinations in dermatology].
Sticherling M
Hautarzt; 2021 Feb; 72(2):100-105. PubMed ID: 33475811
[TBL] [Abstract][Full Text] [Related]
49. 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases.
Furer V; Rondaan C; Heijstek MW; Agmon-Levin N; van Assen S; Bijl M; Breedveld FC; D'Amelio R; Dougados M; Kapetanovic MC; van Laar JM; de Thurah A; Landewé RB; Molto A; Müller-Ladner U; Schreiber K; Smolar L; Walker J; Warnatz K; Wulffraat NM; Elkayam O
Ann Rheum Dis; 2020 Jan; 79(1):39-52. PubMed ID: 31413005
[TBL] [Abstract][Full Text] [Related]
50. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
Zhou W; Pool V; Iskander JK; English-Bullard R; Ball R; Wise RP; Haber P; Pless RP; Mootrey G; Ellenberg SS; Braun MM; Chen RT
MMWR Surveill Summ; 2003 Jan; 52(1):1-24. PubMed ID: 12825543
[TBL] [Abstract][Full Text] [Related]
51. Effectiveness and safety of immunization with live-attenuated and inactivated vaccines for pediatric liver transplantation recipients.
Kawano Y; Suzuki M; Kawada J; Kimura H; Kamei H; Ohnishi Y; Ono Y; Uchida H; Ogura Y; Ito Y
Vaccine; 2015 Mar; 33(12):1440-5. PubMed ID: 25665961
[TBL] [Abstract][Full Text] [Related]
52. In utero exposure to biologic disease-modifying anti-rheumatic drugs and effects to the infant: infectious complications, vaccine response, and safety of live vaccine administration.
Berkhout A; Clark JE; Wen SC
Expert Rev Vaccines; 2019 May; 18(5):495-504. PubMed ID: 30916600
[TBL] [Abstract][Full Text] [Related]
53. Antibody Response to SARS-CoV-2 Vaccination in Patients with Inflammatory Bowel Disease: Results of a Single-Center Cohort Study in a Tertiary Hospital in Germany.
Classen JM; Muzalyova A; Nagl S; Fleischmann C; Ebigbo A; Römmele C; Messmann H; Schnoy E
Dig Dis; 2022; 40(6):719-727. PubMed ID: 34915480
[TBL] [Abstract][Full Text] [Related]
54. Comparative effectiveness and safety of non-tumour necrosis factor biologics and Janus kinase inhibitors in patients with active rheumatoid arthritis showing insufficient response to tumour necrosis factor inhibitors: A Bayesian network meta-analysis of randomized controlled trials.
Sung YK; Lee YH
J Clin Pharm Ther; 2021 Aug; 46(4):984-992. PubMed ID: 33600008
[TBL] [Abstract][Full Text] [Related]
55. From the Medical Board of the National Psoriasis Foundation: Vaccination in adult patients on systemic therapy for psoriasis.
Wine-Lee L; Keller SC; Wilck MB; Gluckman SJ; Van Voorhees AS
J Am Acad Dermatol; 2013 Dec; 69(6):1003-13. PubMed ID: 24075223
[TBL] [Abstract][Full Text] [Related]
56. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.
Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502
[TBL] [Abstract][Full Text] [Related]
57. Single-pill combinations (SPCs) and treatment of arterial hypertension in Poland. Expert consensus statement of the Polish Society of Hypertension and Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy.
Tykarski A; Widecka K; Narkiewicz K; Wożakowska-Kapłon B; Gaciong Z; Grajek S; Grodzicki T; Januszewicz A; Wolf J; Prejbisz A; Kostka-Jeziorny K; Filipiak KJ
Kardiol Pol; 2017; 75(12):1357-1367. PubMed ID: 29251761
[TBL] [Abstract][Full Text] [Related]
58. Vaccination strategies in patients with IBD.
Gisbert JP; Chaparro M
Nat Rev Gastroenterol Hepatol; 2013 May; 10(5):277-85. PubMed ID: 23419290
[TBL] [Abstract][Full Text] [Related]
59. Safety and Efficacy of Covid-19 Vaccination in Patients Undergoing Biological Treatments for Psoriasis.
Potestio L; Martora F; Fabbrocini G; Battista T; Megna M
Psoriasis (Auckl); 2023; 13():11-18. PubMed ID: 37077713
[TBL] [Abstract][Full Text] [Related]
60. Literature-based immunization recommendations for patients requiring immunosuppressive medications for autoimmune bullous dermatoses.
Laniosz V; Lehman JS; Poland GA; Wetter DA
Int J Dermatol; 2016 Jun; 55(6):599-607. PubMed ID: 26711431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
